Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-09

Clinical Trial Update: Comparing Patient Satisfaction With Pataday or Bepreve [NA]

View source ↗

Summary

A completed clinical trial comparing patient satisfaction with Pataday (olopatadine) versus Bepreve (olopatadine) for eye allergies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepreve (bepotastine besilate)
  • Pataday (olopatadine)

Snippet

Sponsor: McCabe Vision Center | Conditions: Eye Allergies | NA | Status: COMPLETED